These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 29027993)

  • 21. Medications for weight reduction.
    Bray GA
    Med Clin North Am; 2011 Sep; 95(5):989-1008. PubMed ID: 21855704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy for weight management.
    Palatty PL; Saldanha E
    J Assoc Physicians India; 2012 Mar; 60():34-40, 45. PubMed ID: 22799113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacotherapy of obesity].
    Svendsen OL
    Ugeskr Laeger; 2004 Oct; 166(43):3814-7. PubMed ID: 15544112
    [No Abstract]   [Full Text] [Related]  

  • 24. The pharmacological and surgical management of adults with obesity.
    Ryan DH
    J Fam Pract; 2014 Jul; 63(7 Suppl):S21-6. PubMed ID: 25198216
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacotherapy for childhood obesity: present and future prospects.
    Sherafat-Kazemzadeh R; Yanovski SZ; Yanovski JA
    Int J Obes (Lond); 2013 Jan; 37(1):1-15. PubMed ID: 22929210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The pharmacotherapy of obesity].
    Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G
    Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New and emerging drug molecules against obesity.
    George M; Rajaram M; Shanmugam E
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):65-76. PubMed ID: 24064009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Weight reduction. Antiobesity drug treatment in type-2 diabetics].
    Verspohl EJ
    Pharm Unserer Zeit; 2002; 31(3):300-7. PubMed ID: 12071127
    [No Abstract]   [Full Text] [Related]  

  • 29. Central and peripheral molecular targets for antiobesity pharmacotherapy.
    Valentino MA; Lin JE; Waldman SA
    Clin Pharmacol Ther; 2010 Jun; 87(6):652-62. PubMed ID: 20445536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
    Grams J; Garvey WT
    Curr Obes Rep; 2015 Jun; 4(2):287-302. PubMed ID: 26627223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incretin pathway as a new therapeutic target for obesity.
    Barber TM; Begbie H; Levy J
    Maturitas; 2010 Nov; 67(3):197-202. PubMed ID: 20655673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacotherapy for obesity in menopausal women.
    Samat A; Rahim A; Barnett A
    Menopause Int; 2008 Jun; 14(2):57-62. PubMed ID: 18519266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological approaches to intervention.
    Guy-Grand B
    Int J Obes Relat Metab Disord; 1997 Mar; 21 Suppl 1():S22-4. PubMed ID: 9130037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug treatment of obesity].
    Svendsen OL; Toubro S; Breum L; Bruun JM; Astrup AV
    Ugeskr Laeger; 2006 Jan; 168(2):163-7. PubMed ID: 16403342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy for obesity.
    Lee PC; Dixon J
    Aust Fam Physician; 2017; 46(7):472-477. PubMed ID: 28697290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic options for modifying cardiometabolic risk factors.
    Aronne LJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S26-34. PubMed ID: 17320519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies.
    Merlotti C; Morabito A; Pontiroli AE
    Diabetes Obes Metab; 2014 Aug; 16(8):719-27. PubMed ID: 24476122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacotherapy for obesity--promise and uncertainty.
    Yanovski SZ
    N Engl J Med; 2005 Nov; 353(20):2187-9. PubMed ID: 16291989
    [No Abstract]   [Full Text] [Related]  

  • 39. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New drugs for the treatment of obesity].
    Mustajoki P
    Duodecim; 1999; 115(20):2191, 2193-4. PubMed ID: 11973921
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.